BP
EMN icon

Ballentine Partners’s Eastman Chemical EMN Stock Holding History

Ballentine Partners’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Buy
3,675
+830
+29% +$60.7K ﹤0.01% 904
2026
Q1 		$217K Buy
+2,845
New +$205K ﹤0.01% 902
2025
Q2 		– Sell
-2,319
Closed -$204K – 1014
2025
Q1 		$204K Buy
+2,319
New +$219K ﹤0.01% 800
2024
Q4 		– Sell
-2,066
Closed -$231K – 909
2024
Q3 		$231K Sell
2,066
-370
-15% -$37K ﹤0.01% 697
2024
Q2 		$239K Buy
+2,436
New +$242K ﹤0.01% 631

Other funds holding EMN

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.12B AUM 44.65% 1-Year Est. Return
QAM
QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return
BHWM
Bar Harbor Wealth Management Concord, New Hampshire $1.86B AUM 32.07% 1-Year Est. Return
KL
KWMG LLC Overland Park, Kansas $1.38B AUM 33.35% 1-Year Est. Return
BCFS
Butensky & Cohen Financial Security Ponte Vedra Beach, Florida $404M AUM 34.65% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Ballentine Partners's EMN Position: Q2 2026 in Review

Ballentine Partners increased its Eastman Chemical (EMN) stake by 29% in Q2 2026, buying an estimated $60.7K and bringing the position to 3,675 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #904.

Ballentine Partners first reported a position in EMN in Q2 2024 and has held it in 5 quarters since. 75 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Ballentine Partners held 3,675 shares of Eastman Chemical worth $246K as of Q2 2026.
  • Ballentine Partners bought 830 Eastman Chemical shares in Q2 2026, an estimated $60.7K.
  • Eastman Chemical made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #904 holding.
  • Ballentine Partners first reported a position in Eastman Chemical in Q2 2024 and has held it in 5 quarters since.
  • 75 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.